Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis
- 20 April 2014
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 34 (10) , 1455-1458
Abstract
We performed this meta-analysis to assess venous thromboembolism risk in patients with idiopathic inflammatory myositis (IIM). A comprehensive search was performed in MEDLINE, EMBASE and the Cochrane database. Three observational studies met our inclusion criteria and were included in the data analysis. The pooled risk ratio of venous thromboembolism in patients with IIM compared with non-IIM participants was 2.85 (95 % CI 2.12–3.84). Our result indicates a significant increased risk of venous thromboembolism among patients with IIM.Keywords
This publication has 17 references indexed in Scilit:
- Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysisClinical Rheumatology, 2014
- Inflammation and thrombosis in cardiovascular diseaseCurrent Opinion in Hematology, 2013
- Clinical Features of Inflammatory Myopathies and Their Association with Malignancy: A Systematic Review in Asian PopulationISRN Rheumatology, 2013
- Venous thromboembolic disease in systemic autoimmune diseases: An association to keep in mindAutoimmunity Reviews, 2012
- Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from SwedenThe Lancet, 2012
- Venous thromboembolism in patients with dermatomyositis and polymyositis.2011
- Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage studyBMC Medicine, 2011
- Deep Venous Thrombosis in DermatomyositisThe Journal of Rheumatology, 2008
- Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?Gut, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986